Eli Lilly and Company

NYSE:LLY

734.57 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 45,042.734,124.128,541.428,318.424,539.822,319.521,493.319,973.821,222.119,958.719,615.623,113.122,603.424,286.523,07621,83620,37818,633.515,69114,645.313,857.912,582.511,077.511,542.510,862.210,002.99,236.88,517.67,346.66,763.85,711.66,452.46,167.35,725.75,191.64,175.64,069.73,643.83,720.43,270.6
Cost of Revenue 8,418.37,082.26,629.87,312.85,483.34,721.24,681.76,070.25,654.95,037.24,932.54,908.14,796.55,067.94,366.24,2474,382.84,248.83,546.53,474.23,223.92,675.12,176.52,160.22,055.71,658.31,524.71,436.21,328.61,3321,247.51,560.71,528.91,354.71,275.81,026.51,132.81,118.51,168.51,039.2
Gross Profit 36,624.427,041.921,911.621,005.619,056.517,598.316,811.613,903.615,567.214,921.514,683.118,20517,806.919,218.618,709.817,58915,995.214,384.712,144.511,171.110,6349,907.48,9019,382.38,806.58,344.67,712.17,081.46,0185,431.84,464.14,891.74,638.44,3713,915.83,149.12,936.92,525.32,551.92,231.4
Gross Profit Ratio 0.8130.7920.7680.7420.7770.7880.7820.6960.7340.7480.7490.7880.7880.7910.8110.8060.7850.7720.7740.7630.7670.7870.8040.8130.8110.8340.8350.8310.8190.8030.7820.7580.7520.7630.7540.7540.7220.6930.6860.682
Reseach & Development Expenses 10,990.69,313.47,190.86,930.76,085.75,5955,051.25,281.85,243.94,796.44,733.65,531.35,278.15,020.84,884.24,326.53,840.93,486.73,129.33,025.52,691.12,350.22,149.32,235.12,018.51,783.61,738.91,370.21,189.51,042.3838.7000000000
General & Administrative Expenses 06,941.25,100.74,901.94,769.44,903.94,834.65,033.4000007,879.97,053.46,892.56,626.46,095.14,889.84,4974,284.24,055.43,4243,417.43,228.32,757.62,658.32,314.41,991.91,8541,398.3000000000
Selling & Marketing Expenses 001,339.71,2401,1001,10090070000000000000000000000000000000000
SG&A 8,593.86,941.26,440.46,141.95,869.46,213.85,734.66,588.16,330.46,5336,620.87,125.67,513.57,879.97,053.46,892.56,626.46,095.14,889.84,4974,284.24,055.43,4243,417.43,228.32,757.62,658.32,314.41,991.91,8541,398.33,840.83,114.82,303.22,128.91,7551,686.11,7461,513.91,330.8
Other Expenses 00007,101.400110.1121.60000000000000000439.7490.4509.8543.5553.7432.2398.3368.1299.5247.5229.3204184.3177.7136.2
Operating Expenses 19,584.416,254.613,631.213,457.512,206.911,808.811,026.311,869.911,695.911,329.411,354.412,656.912,791.612,900.711,937.611,21910,467.39,581.88,019.17,522.56,975.36,405.65,573.35,652.55,246.84,980.94,887.64,206.23,724.93,4502,669.24,239.13,482.92,602.72,376.41,984.31,890.11,930.31,691.61,467
Operating Income 17,501.710,325.48,653.37,302.66,4415,999.46,025.82,1453,871.33,592.13,328.75,548.15,015.36,317.96,772.26,3705,527.94,802.94,125.43,648.63,658.73,501.83,327.73,729.83,559.73,363.72,824.52,438.42,044.31,981.81,794.9652.61,155.51,768.31,539.41,164.81,046.8595860.3764.4
Operating Income Ratio 0.3890.3030.3030.2580.2620.2690.280.1070.1820.180.170.240.2220.260.2930.2920.2710.2580.2630.2490.2640.2780.30.3230.3280.3360.3060.2860.2780.2930.3140.1010.1870.3090.2970.2790.2570.1630.2310.234
Total Other Income Expenses Net -4,821.3-3,770.8-1,846.9-1,147.1788.9-733.5-2,345.7159.8-497.3-802.1-328.4341.2392.9-968.4-247-1,012.2-6,835.5-926.1-707.4-931.1-716.8-240.1130-177.7299-118.3-159.5462.787-216.2-96.349.326.8110.959.6165.16901632.2
Income Before Tax 12,680.46,554.66,806.46,155.57,229.95,265.93,680.12,304.83,3742,7903,000.35,889.35,408.25,349.56,525.25,357.8-1,307.63,876.83,4182,717.52,941.93,261.73,457.73,552.13,858.73,245.42,6652,901.12,131.31,765.61,698.6701.91,182.31,879.21,5991,329.91,115.8595876.3796.6
Income Before Tax Ratio 0.2820.1920.2380.2170.2950.2360.1710.1150.1590.140.1530.2550.2390.220.2830.245-0.0640.2080.2180.1860.2120.2590.3120.3080.3550.3240.2890.3410.290.2610.2970.1090.1920.3280.3080.3180.2740.1630.2360.244
Income Tax Expense 2,090.41,314.2561.6573.81,036.2628529.52,391.2636.4381.6609.81,204.51,319.61,001.81,455.71,029764.3923.8755.3715.91,131.8700.9749.8742.7800.9698.7568.7885.2505.6459513.5210.8354.7564.5471.7390.4354.8184.5318.1279
Net Income 10,5905,240.46,244.85,581.76,193.78,318.43,232-204.12,737.62,408.42,390.54,684.84,088.64,347.75,069.54,328.8-2,071.92,9532,662.71,979.61,810.12,560.82,707.92,7803,057.82,7212,097.9-385.11,523.52,290.91,286.1480.2708.71,314.71,127.3939.5761643.7558.2517.6
Net Income Ratio 0.2350.1540.2190.1970.2520.3730.15-0.010.1290.1210.1220.2030.1810.1790.220.198-0.1020.1580.170.1350.1310.2040.2440.2410.2820.2720.227-0.0450.2070.3390.2250.0740.1150.230.2170.2250.1870.1770.150.158
EPS 11.765.836.936.156.474.983.14-0.192.592.272.234.333.673.94.583.94-1.892.712.451.821.672.382.512.582.832.51.91-0.351.392.021.110.40.611.130.980.80.670.560.510.47
EPS Diluted 11.715.86.96.126.794.963.13-0.192.582.262.234.323.663.94.583.94-1.892.712.451.811.662.372.52.552.792.461.87-0.341.362.021.110.40.611.130.980.80.670.560.510.47
EBITDA 15,227.68,567.88,660.58,042.98,913.46,899.15,531.63,989.75,055.84,378.94,528.17,4957,048.26,909.18,038.96,916.943.35,1534,457.94,3754,256.24,050.33,820.74,184.73,995.53,803.43,314.92,948.22,587.82,535.52,227.11,050.91,523.62,067.81,786.91,394.11,250.8779.31,038900.6
EBITDA Ratio 0.3380.2510.3030.2840.3630.3090.2570.20.2380.2190.2310.3240.3120.2840.3480.3170.0020.2770.2840.2990.3070.3220.3450.3630.3680.380.3590.3460.3520.3750.390.1630.2470.3610.3440.3340.3070.2140.2790.275